Literature DB >> 32156556

Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain.

Rizaldy C Zapata1, Olivia Osborn2.   

Abstract

While both men and women gain weight as a side effect of antipsychotic (AP) treatment, studies in mice have found only female mice are susceptible to weight gain. Therefore, to we set out to identify a strain of male mice that gain significant weight in response to APs which could better model AP-induced weight gain observed in humans. These studies determined that male Balb/c mice developed late onset olanzapine-induced weight gain. Patients often take APs for many years and thus understanding AP-mediated changes in food intake, energy expenditure and body weight regulation is particularly important.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antipsychotic; energy expenditure; food intake; obesity; olanzapine; side-effects; weight gain

Year:  2020        PMID: 32156556      PMCID: PMC7291782          DOI: 10.1016/j.physbeh.2020.112859

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  70 in total

1.  A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.

Authors:  Irit Gil-Ad; Moshe Portnoy; Igor Tarasenko; Miri Bidder; Maria Kramer; Michal Taler; Abraham Weizman
Journal:  Eur Neuropsychopharmacol       Date:  2013-12-16       Impact factor: 4.600

2.  Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.

Authors:  Steve Mann; Araba Chintoh; Adria Giacca; Paul Fletcher; Jose Nobrega; Margaret Hahn; Gary Remington
Journal:  Pharmacol Biochem Behav       Date:  2012-12-09       Impact factor: 3.533

3.  Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking.

Authors:  Sue Lynn Lau; Christopher Muir; Yolinda Assur; Rhonda Beach; Bich Tran; Roger Bartrop; Mark McLean; Dorgival Caetano
Journal:  J Clin Psychopharmacol       Date:  2016-04       Impact factor: 3.153

4.  Gene-by-Sex Interactions in Mitochondrial Functions and Cardio-Metabolic Traits.

Authors:  Frode Norheim; Yehudit Hasin-Brumshtein; Laurent Vergnes; Karthickeyan Chella Krishnan; Calvin Pan; Marcus M Seldin; Simon T Hui; Margarete Mehrabian; Zhiqiang Zhou; Sonul Gupta; Brian W Parks; Axel Walch; Karen Reue; Susanna M Hofmann; Arthur P Arnold; Aldons J Lusis
Journal:  Cell Metab       Date:  2019-01-10       Impact factor: 27.287

5.  Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.

Authors:  Silje Skrede; Johan Fernø; María Jesús Vázquez; Sveinung Fjær; Tina Pavlin; Niclas Lunder; Antonio Vidal-Puig; Carlos Diéguez; Rolf Kristian Berge; Miguel López; Vidar Martin Steen
Journal:  Int J Neuropsychopharmacol       Date:  2011-08-19       Impact factor: 5.176

6.  National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders.

Authors:  Jonathan S Comer; Ramin Mojtabai; Mark Olfson
Journal:  Am J Psychiatry       Date:  2011-07-28       Impact factor: 18.112

Review 7.  Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.

Authors:  Bal Krishan Sharma; Mallikarjun Patil; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

Review 8.  Drug-induced hyperphagia: what can we learn from psychiatric medications?

Authors:  Gordon L Jensen
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Sep-Oct       Impact factor: 4.016

9.  Characterization of olanzapine-induced weight gain in rats.

Authors:  Andrew J Goudie; Judith A Smith; Jason C G Halford
Journal:  J Psychopharmacol       Date:  2002-12       Impact factor: 4.153

10.  Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.

Authors:  Huqun Li; Maosheng Fang; Mingzhen Xu; Shihong Li; Juan Du; Weiyong Li; Hui Chen
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

View more
  3 in total

1.  The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.

Authors:  Li Li; Eun-Seon Yoo; Xiujuan Li; Steven C Wyler; Xiameng Chen; Rong Wan; Amanda G Arnold; Shari G Birnbaum; Lin Jia; Jong-Woo Sohn; Chen Liu
Journal:  J Exp Med       Date:  2021-05-12       Impact factor: 14.307

2.  Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding.

Authors:  Rizaldy C Zapata; Allison Silver; Dongmin Yoon; Besma Chaudry; Avraham Libster; Michael J McCarthy; Olivia Osborn
Journal:  Schizophrenia (Heidelb)       Date:  2022-08-30

3.  Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain.

Authors:  Rizaldy C Zapata; Besma S Chaudry; Mariela Lopez Valencia; Dinghong Zhang; Scott A Ochsner; Neil J McKenna; Olivia Osborn
Journal:  Transl Psychiatry       Date:  2021-07-22       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.